www.bbc.com
Vaccine breakthrough stops cancer returning in trial
A new jab extended the length of time patients were cancer free, but it is unclear for how long.
Science wins, community successes, and quiet progress that never trends — the good news that gets drowned out.
Feed on Blueskywww.bbc.com
Vaccine breakthrough stops cancer returning in trial
A new jab extended the length of time patients were cancer free, but it is unclear for how long.
www.nbcnews.com
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
The companies haven’t published the trial data, but they said the experimental treatment extended the time before cancer returned in high-risk patients.
reut.rs
Moderna, Merck breakthrough could usher in wave of cancer vaccines
Merck and Moderna's success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many types of tumors.
www.forbes.com
Moderna Stock Plunges 25%—Wiping Out $18 Billion After Historic Cancer Vaccine Breakthrough
The biotech giant posted positive trial results of a cancer vaccine, boosting shares at a record-setting pace before investors pulled back.
www.theguardian.com
Otter spotted for first time in 100 years in New York City’s Bronx River
Image captured in early June shows animal foraging in the waterway in first since early 1900s, signaling its recovery
denkstrom.org
Engineered Algae Removes 90 Percent of Microplastics from Wastewater | Good News
Researchers at Texas A&M University have engineered cyanobacteria to remove over 90 percent of microplastic particles from wastewater while simultaneously binding nitrates and phosphates. The results ...
www.bloomberg.com
This Pancreatic Cancer Drug Is So Good, It Got a Standing Ovation
It’s not often that you see a standing ovation at a medical conference. But over the weekend, a ballroom full of cancer specialists got to their feet to applaud a slide showing that Revolution Medicin...
www.statnews.com
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful approach in oncology.
www.bbc.co.uk
Vaccine breakthrough stops cancer returning in trial
A new jab extended the length of time patients were cancer free, but it is unclear for how long.
reut.rs
Moderna, Merck breakthrough could usher in wave of cancer vaccines
Merck and Moderna's success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many types of tumors.